Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (NYSE: CRL) is trading at $292.84, about ₹28,089 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 0.54% today. Indian residents can buy Charles River Laboratories International from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$288.20
Today's high
$295.23
52 week low
$145.47
52 week high
$303.31
CRL opened at $292.95, closed previously at $294.44, and has traded between $145.47 and $303.31 over the past 52 weeks.
About
Charles River Laboratories International, Inc. operates as a contract research organization (CRO), providing essential preclinical services to the pharmaceutical and biotechnology industries. Its core business revolves around assisting clients with drug discovery, non-clinical development, and thorough safety testing, with its services extending globally across the United States, Europe, Canada, and the Asia Pacific region. The company organizes its diverse offerings into three principal segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. 1. Research Models and Services (RMS): This division is a key supplier of high-quality rodent research models, including specially bred strains of rats and mice for experimental purposes. It also offers a comprehensive array of support services to help clients effectively utilize these models in their research and for the screening of potential non-clinical drug candidates. These include providing genetically engineered models, insourcing solutions for facility management, and diagnostic services for research animals. 2. Discovery and Safety Assessment (DSA): The DSA segment plays a crucial role in advancing early-stage drug pipelines. It delivers early-phase and in vivo discovery services focused on identifying and validating new therapeutic targets, chemical compounds, and antibodies. The ultimate goal is to prepare promising non-clinical drug and therapeutic candidates for subsequent safety evaluations. Additionally, this segment provides an extensive range of safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism studies, and pharmacokinetics. 3. Manufacturing Solutions: This segment addresses critical quality control requirements by offering in vitro methods for both routine and rapid testing of the quality of sterile and non-sterile pharmaceuticals, as well as consumer products. It also serves as a vital provider of specialized biologics testing, which is often outsourced by pharmaceutical and biotechnology companies. Furthermore, the segment supplies avian vaccine services, including specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products, all essential for vaccine production. Beyond these specialized segments, Charles River also manages contract vivarium operations, providing crucial animal housing and care facilities for its biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Key statistics
Avg. volume
917.54K
Market cap
$14.11B
P/E Ratio
-60.50
Price-to-sales ratio
3.53
Enterprise value
$16.94B
Free cash flow yield
2.63%
Debt-to-equity ratio
1.07
Return on equity
-7.72%
ROIC
7.72%
Beta
1.41
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$4.02B
Earnings per share
-$2.91
Free cash flow
$518.49M
Net profit margin
-5.96%
Gross margin
32.24%
EBITDA
$410.84M
Revenue growth
-0.85%
Similar securities
This is not an investment recommendation
How to buy Charles River Laboratories International from India
Indian residents can buy Charles River Laboratories International shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Charles River Laboratories International and place an order
Find Charles River Laboratories International by name or by its ticker, CRL, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Charles River Laboratories International trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Charles River Laboratories International position in USD and INR. Charles River Laboratories International pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Charles River Laboratories International from India
Trading and taxes when buying Charles River Laboratories International from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCharles River Laboratories International does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Charles River Laboratories International stock?
Yes. Charles River Laboratories International (CRL) has been listed on the New York Stock Exchange since 2000, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Charles River Laboratories International share cost in rupees?
One Charles River Laboratories International share is $292.84 — about ₹28,089 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Charles River Laboratories International price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Charles River Laboratories International from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy Charles River Laboratories International with less than the price of one share?
Yes. A whole Charles River Laboratories International share is $292.84, but there is no minimum trade size: you enter a rupee or dollar amount and receive the matching fraction.
How are gains on Charles River Laboratories International shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Charles River Laboratories International price. Paasa issues a capital-gains statement for your return.
Does Charles River Laboratories International pay a dividend?
No. Charles River Laboratories International does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Charles River Laboratories International from India?
The New York Stock Exchange trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Charles River Laboratories International shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Charles River Laboratories International shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Charles River Laboratories International holding, its cost and its closing value.
How do I sell Charles River Laboratories International and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.